Shanghai Minwei Biotechnology Co., Ltd
5 clinical trials · Sponsor
◉ Watch Shanghai Minwei Biotechnology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity (NCT07778693) | Shanghai Minwei Biotechnology Co., Ltd | 2026-09-01 |
| Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants (NCT07779980) | Shanghai Minwei Biotechnology Co., Ltd | 2026-08-26 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205 (NCT07634510) | Shanghai Minwei Biotechnology Co., Ltd | 2026-06-22 |
| A Study to Evaluate MWN109 Tablets in Healthy Adult Participants (NCT06938269) | Shanghai Minwei Biotechnology Co., Ltd | 2025-06-18 |
| A Study to Evaluate MWN109 Injection in Healthy Subjects (NCT06859853) | Shanghai Minwei Biotechnology Co., Ltd | 2025-03-17 |
Track Shanghai Minwei Biotechnology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.